ICD-10 Code B78.7 | Disseminated strongyloidiasis Symptoms, Diagnosis, Billing

Disseminated strongyloidiasis is a severe form of infection caused by the parasitic nematode Strongyloides stercoralis. This condition can lead to systemic illness, particularly in immunocompromised individuals. Accurate coding with ICD-10 Code B78.7 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.

What is ICD-10 Code B78.7 for Disseminated strongyloidiasis?

ICD-10 Code B78.7 specifically denotes disseminated strongyloidiasis, which occurs when Strongyloides stercoralis spreads beyond the gastrointestinal tract, potentially affecting multiple organ systems. This code should be used when documenting cases of severe infection, particularly in patients with compromised immune systems, to ensure accurate billing and appropriate clinical management.

ICD-10 Code B78.7 – Clinical Definition and Explanation of Disseminated strongyloidiasis

Disseminated strongyloidiasis is primarily caused by the autoinfection cycle of Strongyloides stercoralis, which can lead to severe complications, especially in immunocompromised patients. Prompt recognition and treatment are crucial to prevent life-threatening outcomes.

Key Clinical Features:

• Severe abdominal pain and gastrointestinal symptoms.
• Respiratory distress due to pulmonary involvement.
• Skin rashes or lesions indicating disseminated infection.
• Neurological symptoms in advanced cases.

ICD-10 Code B78.7 for Disseminated strongyloidiasis – SOAP Notes & Clinical Use

ICD-10 Code B78.7 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of disseminated strongyloidiasis. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management.

What Does ICD-10 Code B78.7 for Disseminated strongyloidiasis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B78.7 connects subjective patient reports and objective clinical findings to a formal diagnosis of disseminated strongyloidiasis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B78.7 – Disseminated strongyloidiasis

Disseminated strongyloidiasis requires urgent medical intervention, often necessitating hospitalization for effective management.

Antibiotic Therapy:

• Ivermectin: First-line treatment, typically administered as a single dose or repeated doses based on clinical response.
• Albendazole: Alternative treatment option, usually given for 7 days.
• Supportive antibiotics may be indicated for secondary infections.

Supportive Care:

• Fluid and electrolyte management to prevent dehydration.
• Symptomatic treatment for pain and gastrointestinal distress.
• Monitoring for complications such as sepsis or respiratory failure.

Infection Control:

• Strict hand hygiene practices to prevent transmission.
• Isolation precautions for immunocompromised patients.
• Education on avoiding exposure to contaminated soil or water.

How to Document Symptoms of Disseminated strongyloidiasis (ICD-10 B78.7) in SOAP Notes

Subjective:

• Patient reports severe abdominal pain and diarrhea.
• History of immunosuppression due to corticosteroid therapy.
• Complaints of skin rashes and respiratory symptoms.
• Recent travel to endemic areas.

Objective:

• Vital signs: Fever of 101°F, tachycardia.
• Abdominal examination reveals tenderness and distension.
• Pulmonary examination shows wheezing and decreased breath sounds.
• Skin examination reveals urticarial lesions.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Disseminated strongyloidiasis (ICD-10 Code B78.7)

Assessment:

• Diagnosis: Disseminated strongyloidiasis, severe.
• ICD-10 Code: B78.7.
• Contributing factors: Immunocompromised state, recent travel history.
• Consideration of secondary infections.

Plan:

• Initiate treatment with Ivermectin as per guidelines.
• Provide supportive care including IV fluids and electrolyte monitoring.
• Educate patient on infection control measures.
• Schedule follow-up in 1 week to assess treatment response.

Treatment & Plan Section for ICD-10 Code B78.7 – Disseminated strongyloidiasis

• First-line pharmacologic treatment: Ivermectin.
• Non-pharmacologic strategies: Education on hygiene and infection prevention.
• Monitoring practices: Regular assessment of vital signs and symptom resolution.
• Follow-up recommendations: Re-evaluate in 1 week or sooner if symptoms worsen.

Using ICD-10 Code B78.7 for Disseminated strongyloidiasis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical severity and complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond with the services provided.

Related ICD-10 Codes Often Used with Disseminated strongyloidiasis

• B78.0 – Strongyloidiasis, intestinal
• B78.1 – Strongyloidiasis, cutaneous
• B20 – HIV disease

ICD-10 Code B78.7 in Medical Billing and Insurance for Disseminated strongyloidiasis

ICD-10 Code B78.7 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed clinical findings and treatment plans.
• Use this code in conjunction with relevant clinical services for comprehensive billing.
• Highlight any complications or comorbidities in the patient's chart.
• Maintain compliance with coding guidelines to avoid claim denials.

Common CPT Pairings: